ERSP
This article was originally published in The Rose Sheet
Executive Summary
DermaRadiant should discontinue claims that its Anti-Wrinkle Complex is "clinically proven" to improve appearance of wrinkle depth in direct-response marketing since testing of the product did not produce statistically significant results, according to Electronic Retailing Self-Regulation Program. However, the study did support general efficacy claims, watchdog group says in recent decision. ERSP also recommended DermaRadiant discontinue implied comparative claims referencing plastic surgery, such as "No Risk Injections. No Costly Doctor Visits and Prescriptions. No Painful Surgery." In a separate case, ERSP requested DermaRadiant discontinue testimonials for Ageless Eyes that product offers immediate results. Group found various performance claims for the formula were supported by clinical studies...